Silberman David
Insider CIK 1867998 · CGEN Chief Financial Officer · ORMP Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CGEN COMPUGEN LTD | A Award deriv | 2026-07-29 | 2026-07-30 | 26,000 | — | $0 | 26,000 | SEC↗ |
| CGEN COMPUGEN LTD | A Award | 2026-07-29 | 2026-07-30 | 19,500 | — | $0 | 55,000 | SEC↗ |
| CGEN COMPUGEN LTD | A Award deriv | 2026-07-29 | 2026-07-30 | 26,000 | — | $0 | 26,000 | SEC↗ |
| CGEN COMPUGEN LTD | A Award | 2026-07-29 | 2026-07-30 | 19,500 | — | $0 | 55,000 | SEC↗ |
| ORMP ORAMED PHARMACEUTICALS INC | A Award | 2024-01-04 | 2024-01-08 | 136,500 | — | $0 | 366,500 | SEC↗ |
| ORMP ORAMED PHARMACEUTICALS INC | A Award | 2023-05-26 | 2023-05-31 | 24,500 | — | $0 | 230,000 | SEC↗ |
| ORMP ORAMED PHARMACEUTICALS INC | A Award | 2023-04-17 | 2023-04-20 | 97,500 | — | $0 | 205,500 | SEC↗ |
| ORMP ORAMED PHARMACEUTICALS INC | A Award | 2022-07-28 | 2022-08-01 | 39,000 | — | $0 | 108,000 | SEC↗ |
| ORMP ORAMED PHARMACEUTICALS INC | A Award deriv | 2022-01-03 | 2022-01-05 | 32,000 | — | $0 | 32,000 | SEC↗ |
| ORMP ORAMED PHARMACEUTICALS INC | A Award | 2022-01-03 | 2022-01-05 | 19,000 | — | $0 | 69,000 | SEC↗ |
| ORMP ORAMED PHARMACEUTICALS INC | A Award deriv | 2021-09-01 | 2021-09-02 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ORMP ORAMED PHARMACEUTICALS INC | A Award | 2021-09-01 | 2021-09-02 | 50,000 | — | $0 | 50,000 | SEC↗ |